Clene Inc (CLNN US)

Health Care • United States

Clene Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development of unique therapeutics for neurodegenerative diseases. Clene provides nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs.

Refresh

No events found

We’ll display events we find for Clene Inc here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00